Baird Medical director holds 18.2M BDMD shares

Baird Medical Investment Holdings Ltd director and 10% owner Wu Haimei has reported a direct holding of 18,195,281 Ordinary Shares of BDMD.

Accepted by SEC EDGAR 03/27/2026 - 06:35 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Baird Medical Investment Holdings Ltd director and 10% owner Wu Haimei has reported a direct holding of 18,195,281 Ordinary Shares of BDMD. The Form 3 entry reflects this ownership position, with no associated buy or sell transactions indicated in the data provided.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider WU HAIMEI

Role Director, 10% Owner

Type	Security	Shares	Price	Value
Holding	Ordinary Share (BDMD)	--	--	--

Holdings: Ordinary Share (BDMD) — 18,195,281 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Baird Medical (BDMD) shares does Wu Haimei hold?

Wu Haimei is reported as directly holding 18,195,281 Ordinary Shares of BDMD. This figure comes from the ownership line showing total shares following the reported holding entry in the Form 3 insider data.

What is Wu Haimei’s role at Baird Medical (BDMD)?

Wu Haimei is listed as a director and a ten percent owner of Baird Medical Investment Holdings Ltd. These roles are explicitly indicated in the insider information for the reporting person in the filing data.

Is Wu Haimei’s BDMD share ownership direct or indirect?

The filing shows Wu Haimei’s ownership as direct. The record marks the ownership type as direct, with the code “D” and no separate entity listed for indirect or delegated ownership.

Does the Wu Haimei Form 3 for BDMD show any recent trades?

The data provided shows no buy or sell transactions for Wu Haimei. Transaction counts for purchases, sales, exercises, gifts, tax withholding, and restructuring are all listed as zero, indicating only a holding entry is reported.

What security is reported for Wu Haimei in the BDMD Form 3?

The security reported is Ordinary Share (BDMD). The Form 3 data identifies this as the security title associated with Wu Haimei’s 18,195,281-share direct holding in Baird Medical Investment Holdings Ltd.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

WU HAIMEI

(Last) (First) (Middle)

15 RONG TONG STREET

(Street)

GUANGZHOU 510030

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/27/2026

3. Issuer Name and Ticker or Trading Symbol
Baird Medical Investment Holdings Ltd [ BDMD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Share (BDMD)	18,195,281	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ HAIMEI WU	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)